Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Feb 28, 2016; 22(8): 2585-2591
Published online Feb 28, 2016. doi: 10.3748/wjg.v22.i8.2585
Table 1 Baseline characteristics of gastrectomy patients
CharacteristicTotal(n = 1776)No active TB(n = 1760)Active TB(n = 16)P value
Age (yr)58 (20-89)58 (20-89)54 (40-83)0.395
< 40169 (9.5)168 (9.5)1 (6.3)
41-60843 (47.5)834 (47.4)9 (56.3)
61-80743 (41.8)738 (41.9)5 (31.3)
> 8021 (1.2)20 (1.1)1 (6.3)
Sex, male1156 (65.1)1142 (64.9)14 (87.5)0.059
Smoking887 (49.9)873 (49.6)14 (87.5)0.010
Alcohol591 (33.4)579 (33.0)12 (75.0)0.001
BMI1 (kg/m2)23.4 (21.5-25.2)23.4 (21.5-25.2)22.4 (18.5-23.9)0.015
< 18.571 (4.0)67 (3.8)4 (25.0)< 0.001
18.5-24.991219 (68.8)1208 (68.8)11 (68.8)
≥ 25482 (27.2)481 (27.4)1 (0.2)
Postoperative BMI2 (kg/m2)21.3 (19.5-23.1)21.3 (19.5-23.1)18.8 (18.2-20.6)0.001
Comorbidity
Diabetes mellitus173 (9.7)171 (9.7)2 (12.5)0.664
Other malignancy36 (2.0)36 (2.0)0 (0.0)1.000
Previous TB infection200 (11.3)191 (10.9)9 (56.3)< 0.001
Laboratory data
Hemoglobin (g/dL)13.8 (12.6-14.8)13.8 (12.6-14.8)13.6 (12.4-14.6)0.340
Albumin (g/dL)4.6 (4.4-4.8)4.6 (4.4-4.8)4.6 (4.3-4.9)0.195
Cholesterol (mg/dL)182 (160-206)182 (160-206)177 (152-190)0.120
ASA physical status0.222
Class I1241 (69.9)1226 (69.7)15 (93.8)
Class II495 (27.9)494 (28.1)1 (6.3)
Class III40 (2.2)40 (2.2)0
Surgery extent, total gastrectomy359 (20.2)351 (19.9)8 (50.0)0.007
Cancer stage0.616
IA1255 (70.6)1245 (70.7)10 (62.5)
IB253 (14.2)252 (14.3)1 (6.3)
II156 (8.8)153 (8.7)3 (18.8)
III94 (5.3)92 (5.2)2 (12.5)
IV5 (0.3)5 (0.3)0 (0)
Cancer cell type0.762
Adenocarcinoma1239 (69.7)1227 (69.7)12 (75.0)
Signet-ring cell454 (25.6)451 (25.6)3 (18.7)
Others72 (4.0)71 (4.0)1 (6.2)
Death42 (2.4)53 (3.0)1 (6.3)0.391